10.1530/REP-13-0111 [DOI] [PubMed] [Google Scholar] 33.Linkova NS, Drobintseva AO, Orlova OA, Kuznetsova EP, Polyakova VO, Kvetnoy IM, Khavinson VK
Unlike traditional treatments that target only CSF production, GLP-1 agonists may work through two pathways: Weight loss - a major long-term treatment for IIH Possible CSF pressure effects - GLP-1 receptors on the choroid plexus (where CSF is made) may reduce fluid secretion independent of weight loss The IIH Pressure Trial ( Brain , 2023) found that exenatide lowered intracranial pressure within hours of the first dose
And the money guy who will not be named, got in, and he was also very successful still is, you know, with the companies, he owns deals a software company thats worth like 150 million, he still hasnt sold it
: :
Several experiments have demonstrated that it accelerates the healing process of tissues, including transected rat Achilles tendon [5]